Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Jul;33(4):e13721.
doi: 10.1111/dth.13721. Epub 2020 Jul 7.

Treatment of bullous pemphigoid in Chinese patients with Tripterygium wilfordii Hook F

Xiao-Lei Ge  1   2 , Si-Zhe Li  1 , Xinxing Jin  1 , Hong-Zhong Jin  1 , Ya-Gang Zuo  1
Affiliations

Treatment of bullous pemphigoid in Chinese patients with Tripterygium wilfordii Hook F

Xiao-Lei Ge et al. Dermatol Ther. 2020 Jul.

Abstract

Tripterygium wilfordii Hook F (TwHF) is a traditional Chinese herb used in many medicinal applications, but the treatment of bullous pemphigoid (BP) with TwHF has never been reported. The aim of this study was to evaluate the efficacy and safety of TwHF in BP patients. A retrospective study was performed from January 2015 to September 2019 in the Department of Dermatology, Peking Union Medical College Hospital. A total of 10 patients with mild to moderate BP and treated with TwHF were enrolled in the study with 10 mild or moderate BP patients treated with systemic glucocorticoid randomly selected as controls. In the TwHF group, a major response was seen in seven patients, a minor response in one and no response was seen in two patients. In the glucocorticoid group, a major response was seen in nine patients and a minor response in one patient. Two patients experienced treatment failure. The time to disease control in the TwHF group (34 ± 11 days) was longer as compared to the glucocorticoid group (18 ± 8 days, P < .05). Ten patients relapsed during the follow-up period. The adverse events in the TwHF group were lower than those in the glucocorticoid group (13 vs 19). Low-dose TwHF may be effective and safe for treating mild and moderate BP.

Keywords: Tripterygium wilfordii Hook F; bullous pemphigoid; efficacy; safety.

PubMed Disclaimer

References

REFERENCES

    1. Feliciani C, Joly P, Jonkman MF, et al. Management of bullous pemphigoid: the European Dermatology Forum consensus in collaboration with the European Academy of Dermatology and Venereology. Br J Dermatol. 2015;172(4):867-877. https://doi.org/10.1111/bjd.13717.
    1. Venning VA, Taghipour K, Mohd Mustapa MF, Highet AS, Kirtschig G. British Association of Dermatologists' guidelines for the management of bullous pemphigoid 2012. Br J Dermatol. 2012;167(6):1200-1214. https://doi.org/10.1111/bjd.12072.
    1. Fisch A, Morin L, Talme T, Johnell K, Gallais Sérézal I. Low-dose methotrexate use and safety for older patients with bullous pemphigoid and impaired renal function: a cohort study. J Am Acad Dermatol. 2020;82(6):1532-1534. https://doi.org/10.1016/j.jaad.2020.01.084.
    1. Bağcı IS, Horváth ON, Ruzicka T, Sárdy M. Bullous pemphigoid. Autoimmun Rev. 2017;16(5):445-455. https://doi.org/10.1016/j.autrev.2017.03.010.
    1. Wang Z, Yu C, Zhou LN, Chen X. Effects of Tripterygium wilfordii induction therapy to IgA nephropathy patients with heavy proteinuria. Biol Pharm Bull. 2017;40(11):1833-1838. https://doi.org/10.1248/bpb.b17-00134.

Publication types

LinkOut - more resources